Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Parkinson's disease and long-term exposure to outdoor air pollution: A matched case-control study in the Netherlands.

Toro R, Downward GS, van der Mark M, Brouwer M, Huss A, Peters S, Hoek G, Nijssen P, Mulleners WM, Sas A, van Laar T, Kromhout H, Vermeulen R.

Environ Int. 2019 Aug;129:28-34. doi: 10.1016/j.envint.2019.04.069. Epub 2019 May 16.

2.

Development and psychometric validation of the headache screening questionnaire - Dutch Version.

van der Meer HA, Visscher CM, Engelbert RHH, Mulleners WM, Nijhuis-van der Sanden MWG, Speksnijder CM.

Musculoskelet Sci Pract. 2017 Oct;31:52-61. doi: 10.1016/j.msksp.2017.07.001. Epub 2017 Jul 4.

3.

Environmental exposure to pesticides and the risk of Parkinson's disease in the Netherlands.

Brouwer M, Huss A, van der Mark M, Nijssen PCG, Mulleners WM, Sas AMG, van Laar T, de Snoo GR, Kromhout H, Vermeulen RCH.

Environ Int. 2017 Oct;107:100-110. doi: 10.1016/j.envint.2017.07.001. Epub 2017 Jul 10.

PMID:
28704700
4.

WITHDRAWN: Anticonvulsant drugs for migraine prophylaxis.

Chronicle EP, Mulleners WM.

Cochrane Database Syst Rev. 2016 May 27;(5):CD003226. doi: 10.1002/14651858.CD003226.pub3. Review. No abstract available.

PMID:
27233055
5.

Occupational exposure to solvents, metals and welding fumes and risk of Parkinson's disease.

van der Mark M, Vermeulen R, Nijssen PC, Mulleners WM, Sas AM, van Laar T, Huss A, Kromhout H.

Parkinsonism Relat Disord. 2015 Jun;21(6):635-9. doi: 10.1016/j.parkreldis.2015.03.025. Epub 2015 Apr 9.

6.

Antiepileptics in migraine prophylaxis: an updated Cochrane review.

Mulleners WM, McCrory DC, Linde M.

Cephalalgia. 2015 Jan;35(1):51-62. doi: 10.1177/0333102414534325. Epub 2014 Aug 12. Review.

PMID:
25115844
7.

Occupational exposure to pesticides and endotoxin and Parkinson disease in the Netherlands.

van der Mark M, Vermeulen R, Nijssen PC, Mulleners WM, Sas AM, van Laar T, Brouwer M, Huss A, Kromhout H.

Occup Environ Med. 2014 Nov;71(11):757-64. doi: 10.1136/oemed-2014-102170. Epub 2014 Aug 7.

PMID:
25104429
8.

Extremely low-frequency magnetic field exposure, electrical shocks and risk of Parkinson's disease.

van der Mark M, Vermeulen R, Nijssen PC, Mulleners WM, Sas AM, van Laar T, Kromhout H, Huss A.

Int Arch Occup Environ Health. 2015 Feb;88(2):227-34. doi: 10.1007/s00420-014-0949-2. Epub 2014 Jun 18.

PMID:
24939428
9.

A case-control study of the protective effect of alcohol, coffee, and cigarette consumption on Parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking.

van der Mark M, Nijssen PC, Vlaanderen J, Huss A, Mulleners WM, Sas AM, van Laar T, Kromhout H, Vermeulen R.

PLoS One. 2014 Apr 30;9(4):e95297. doi: 10.1371/journal.pone.0095297. eCollection 2014.

10.

Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.

Linde M, Mulleners WM, Chronicle EP, McCrory DC.

Cochrane Database Syst Rev. 2013 Jun 24;(6):CD010611. doi: 10.1002/14651858.CD010611. Review.

PMID:
23797677
11.

Topiramate for the prophylaxis of episodic migraine in adults.

Linde M, Mulleners WM, Chronicle EP, McCrory DC.

Cochrane Database Syst Rev. 2013 Jun 24;(6):CD010610. doi: 10.1002/14651858.CD010610. Review.

PMID:
23797676
12.

Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults.

Linde M, Mulleners WM, Chronicle EP, McCrory DC.

Cochrane Database Syst Rev. 2013 Jun 24;(6):CD010609. doi: 10.1002/14651858.CD010609. Review.

13.

Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults.

Linde M, Mulleners WM, Chronicle EP, McCrory DC.

Cochrane Database Syst Rev. 2013 Jun 24;(6):CD010608. doi: 10.1002/14651858.CD010608. Review.

PMID:
23797674
14.

[Autoimmune limbic encephalitis: importance of early diagnosis and treatment].

van Vliet J, Meulstee J, Hartong EG, Mulleners WM.

Ned Tijdschr Geneeskd. 2012;156(16):A4455. Dutch.

PMID:
22510418
15.

[Preventive treatment for migraine].

Mulleners WM, Haan J, Dekker F, Ferrari MD.

Ned Tijdschr Geneeskd. 2010;154:A1512. Review. Dutch.

PMID:
20699036
16.

Anticonvulsants in migraine prophylaxis: a Cochrane review.

Mulleners WM, Chronicle EP.

Cephalalgia. 2008 Jun;28(6):585-97. doi: 10.1111/j.1468-2982.2008.01571.x. Review.

PMID:
18454787
17.

Botulinum toxin A for drooling in Parkinson's disease: a pilot study to compare submandibular to parotid gland injections.

Kalf JG, Smit AM, Bloem BR, Zwarts MJ, Mulleners WM, Munneke M.

Parkinsonism Relat Disord. 2007 Dec;13(8):532-4. Epub 2007 Mar 26.

PMID:
17383926
18.

Objective assessment of cortical excitability in migraine with and without aura.

Chronicle EP, Pearson AJ, Mulleners WM.

Cephalalgia. 2006 Jul;26(7):801-8.

PMID:
16776694
19.
20.

Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness.

Aurora SK, Barrodale P, Chronicle EP, Mulleners WM.

Headache. 2005 May;45(5):546-52.

PMID:
15953273
21.

Colour vision impairment in migraine--out of the blue?

Mulleners WM.

Cephalalgia. 2005 Jun;25(6):401-2. No abstract available.

PMID:
15910563
22.

Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS.

Mulleners WM, Chronicle EP, Vredeveld JW, Koehler PJ.

Eur J Neurol. 2002 Jan;9(1):35-40.

PMID:
11784374
23.

Visual cortex excitability in migraine with and without aura.

Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld JW.

Headache. 2001 Jun;41(6):565-72.

PMID:
11437892
24.

Self-reported photophobic symptoms in migraineurs and controls are reliable and predict diagnostic category accurately.

Mulleners WM, Aurora SK, Chronicle EP, Stewart R, Gopal S, Koehler PJ.

Headache. 2001 Jan;41(1):31-9.

PMID:
11168601
25.

Suppression of perception in migraine: evidence for reduced inhibition in the visual cortex.

Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld JW.

Neurology. 2001 Jan 23;56(2):178-83.

PMID:
11160952
26.

Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients.

Palmer JE, Chronicle EP, Rolan P, Mulleners WM.

Cephalalgia. 2000 Jul;20(6):525-32.

PMID:
11075834
27.

Cortical excitability in migraine.

Mulleners WM, Chronicle EP, Vredeveld JW, Koehler PJ.

Ann Neurol. 1999 Mar;45(3):415-6. No abstract available.

PMID:
10072064
28.

Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better.

Mulleners WM, Whitmarsh TE, Steiner TJ.

Cephalalgia. 1998 Jan;18(1):52-6.

PMID:
9601625
29.

Spinal muscular atrophy combined with congenital heart disease: a report of two cases.

Mulleners WM, van Ravenswaay CM, Gabreƫls FJ, Hamel BC, van Oort A, Sengers RC.

Neuropediatrics. 1996 Dec;27(6):333-4. No abstract available.

PMID:
9050054
30.

Visual system dysfunction in migraine: a review of clinical and psychophysical findings.

Chronicle EP, Mulleners WM.

Cephalalgia. 1996 Dec;16(8):525-35; discussion 523. Review.

PMID:
8980853
31.

Cluster-tic syndrome.

Mulleners WM, Verhagen WI.

Neurology. 1996 Jul;47(1):302. No abstract available.

PMID:
8710105
32.

Cerebral salt wasting syndrome.

Mulleners WM, Verhagen WI, Bartels RH.

J Neurol Neurosurg Psychiatry. 1996 Feb;60(2):234-5. No abstract available.

Supplemental Content

Loading ...
Support Center